Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Betulin
60
CHF
CHF 60.00
In stock
AG-CN2-0476-M250250 mgCHF 60.00
AG-CN2-0476-G0011 gCHF 120.00
Product Details | |
---|---|
Synonyms | Betulinol; Trochol; NSC 4644 |
Product Type | Chemical |
Properties | |
Formula |
C30H50O2 |
MW | 442.7 |
Merck Index | 14: 1198 |
CAS | 473-98-3 |
RTECS | OK5755000 |
Source/Host Chemicals | Isolated from Betulaceae family tree bark. |
Purity Chemicals | ≥98% (NMR) |
Appearance | White solid. |
Solubility | Soluble in DMSO, DMF or ethanol. |
Identity | Determined by 1H-NMR. |
InChi Key | FVWJYYTZTCVBKE-ROUWMTJPSA-N |
Smiles | [H][C@]12[C@@H](CC[C@]1(CO)CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(C)=C |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Specific SREBPs (sterol regulatory element-binding proteins) inhibitor. Inhibits ER-Golgi translocation of SREBPs through binding to SCAP in an INSIG-dependent manner.
- Improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Lowers cholesterol levels through inhibition of SREBP-2 activation. Reduces weight gain and adipose tissue size in vivo. Increases oxygen consumption and energy expenditure. Increases UCP1/2 levels in brown adipose tissue (BAT) after cold stimulation.
- Anticancer compound. Apoptosis inducer. DNA topoisomerase II inhibitor.
- Anti-inflammatory compound. Shown to inhibit LPS-induced NO production through the TLR4/NF-κB signaling pathway.
- Antiviral compound.
Product References
- Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity: S. Wada, et al.; J. Nat. Prod. 64, 1545 (2001)
- The synergistic effects of betulin with acyclovir against herpes simplex viruses: Y. Gong, et al.; Antiviral Res. 64, 127 (2004)
- Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques: J.J. Tang, et al.; Cell Metab. 13, 44 (2011)
- A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products: J.R. Krycer, et al.; Biochem. J. 446, 191 (2012)
- Targeting SREBPs for treatment of the metabolic syndrome: S.M. Soyal, et al.; Trends Pharmacol. Sci. 36, 406 (2015)
- Induction of apoptotic cell death by betulin in multidrug-resistant human renal carcinoma cells: N.H. Yim, et al.; Oncol. Rep. 34, 1058 (2015)
- Comprehensive review on betulin as a potent anticancer agent: S.K. Krol, et al.; Biomed. Res. Int. 2015 (Review)
- Betulin derivatives effectively suppress inflammation in vitro and in vivo: M. Laavola, et al.; J. Nat. Prod. 79, 274 (2016)
- Betulin attenuates kidney injury in septic rats through inhibiting TLR4/NF-κB signaling pathway: H. Zhao, et al.; Life Sci. 144, 185 (2016)